Published: 14 April 2020
Author(s): Maribel González-del-Hoyo, Anna Carrasquer, Gil Bonet, Isabel Fort-Gallifa, Alfredo Bardají
Issue: August 2020
Section: Letter to the Editor

Atrial fibrillation (AF) is the most common arrhythmia in clinical practice, and is associated with an increased risk of stroke, heart failure (HF) and mortality [1]. In this regard, the CHA2DS2-VASc score is a well-known predictor of stroke in patients with AF, with some studies evaluating its use as a marker for predicting all-cause death [2,3]. Cardiac troponin I (cTnI) has consistently provided prognostic information on the risk of stroke, vascular events and mortality in patients with AF [4].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.